|172.81||0.00 / 0.00%|
As of Mar 31
|172.96||+0.15 / +0.09%|
The 12 analysts offering 12-month price forecasts for Salix Pharmaceuticals Ltd have a median target of 158.00, with a high estimate of 173.00 and a low estimate of 107.00. The median estimate represents a -8.57% decrease from the last price of 172.81.
The current consensus among 16 polled investment analysts is to Hold stock in Salix Pharmaceuticals Ltd. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.